Differential effects of lipoprotein lipase on tumor necrosis factor-α and interferon-γ-mediated gene expression in human endothelial cells

Rama S. Kota, Chilakamarti V. Ramana, Fatima A. Tenorio, Richard I. Enelow, John C Rutledge

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Lipoprotein lipase (LPL) is a key enzyme in the hydrolysis of triglyceride-rich lipoproteine. In vascular diseases, such as atherosclerosis, inflammation plays an important role in the pathogenesis of the disease. We examined the role of LPL in modulating tumor necrosis factor-α (TNF-α)- and interferon-γ (IFN-γ)-mediated inflammatory cytokine signal transduction pathways in human aortic endothelial cells (HAECs). LPL significantly suppressed TNF-α-induced gene expression, and this suppression was reversed by tetrahydrolipstatin and heparinase. In contrast, LPL synergistically enhanced IFN-γ-induced gene expression in HAECs. To elucidate the molecular mechanisms of LPL action, we investigated the role of transcription factors nuclear factor kappa B (NF-κB) and signal transducer and activator of transcription factor 1 (Stat1). The anti-inflammatory response of LPL in suppressing TNF-α-induced gene expression was a result of its inhibition of NF-κB activity by the abrogation of IκB-α degradation and phosphorylation of the p65 subunit. Although LPL alone had no effect on Stat1 activation, LPL enhanced IFN-γ-induced phosphorylation of Stat1 on tyrosine 701 and serine 727, as well as Stat1-mediated transactivation. The synergistic effect of LPL on IFN-γ-induced Stat1 activation was mediated by enhanced activation of the tyrosine kinase JAK2 and was abrogated by LY294002, a specific inhibitor of the phosphatidylinositol 3′-kinase pathway. Our studies indicate that LPL has differential effects on several inflammatory pathways known to be important in atherosclerosis.

Original languageEnglish (US)
Pages (from-to)31076-31084
Number of pages9
JournalJournal of Biological Chemistry
Volume280
Issue number35
DOIs
StatePublished - Sep 2 2005

Fingerprint

Lipoprotein Lipase
Endothelial cells
Gene expression
Interferons
Endothelial Cells
Tumor Necrosis Factor-alpha
STAT1 Transcription Factor
Gene Expression
Transcription Factors
Transducers
Phosphorylation
NF-kappa B
Chemical activation
Atherosclerosis
Heparin Lyase
Phosphatidylinositol 3-Kinase
Signal transduction
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Vascular Diseases
Protein-Tyrosine Kinases

ASJC Scopus subject areas

  • Biochemistry

Cite this

Differential effects of lipoprotein lipase on tumor necrosis factor-α and interferon-γ-mediated gene expression in human endothelial cells. / Kota, Rama S.; Ramana, Chilakamarti V.; Tenorio, Fatima A.; Enelow, Richard I.; Rutledge, John C.

In: Journal of Biological Chemistry, Vol. 280, No. 35, 02.09.2005, p. 31076-31084.

Research output: Contribution to journalArticle

Kota, Rama S. ; Ramana, Chilakamarti V. ; Tenorio, Fatima A. ; Enelow, Richard I. ; Rutledge, John C. / Differential effects of lipoprotein lipase on tumor necrosis factor-α and interferon-γ-mediated gene expression in human endothelial cells. In: Journal of Biological Chemistry. 2005 ; Vol. 280, No. 35. pp. 31076-31084.
@article{967da2a888e648aaa43757ed505ff883,
title = "Differential effects of lipoprotein lipase on tumor necrosis factor-α and interferon-γ-mediated gene expression in human endothelial cells",
abstract = "Lipoprotein lipase (LPL) is a key enzyme in the hydrolysis of triglyceride-rich lipoproteine. In vascular diseases, such as atherosclerosis, inflammation plays an important role in the pathogenesis of the disease. We examined the role of LPL in modulating tumor necrosis factor-α (TNF-α)- and interferon-γ (IFN-γ)-mediated inflammatory cytokine signal transduction pathways in human aortic endothelial cells (HAECs). LPL significantly suppressed TNF-α-induced gene expression, and this suppression was reversed by tetrahydrolipstatin and heparinase. In contrast, LPL synergistically enhanced IFN-γ-induced gene expression in HAECs. To elucidate the molecular mechanisms of LPL action, we investigated the role of transcription factors nuclear factor kappa B (NF-κB) and signal transducer and activator of transcription factor 1 (Stat1). The anti-inflammatory response of LPL in suppressing TNF-α-induced gene expression was a result of its inhibition of NF-κB activity by the abrogation of IκB-α degradation and phosphorylation of the p65 subunit. Although LPL alone had no effect on Stat1 activation, LPL enhanced IFN-γ-induced phosphorylation of Stat1 on tyrosine 701 and serine 727, as well as Stat1-mediated transactivation. The synergistic effect of LPL on IFN-γ-induced Stat1 activation was mediated by enhanced activation of the tyrosine kinase JAK2 and was abrogated by LY294002, a specific inhibitor of the phosphatidylinositol 3′-kinase pathway. Our studies indicate that LPL has differential effects on several inflammatory pathways known to be important in atherosclerosis.",
author = "Kota, {Rama S.} and Ramana, {Chilakamarti V.} and Tenorio, {Fatima A.} and Enelow, {Richard I.} and Rutledge, {John C}",
year = "2005",
month = "9",
day = "2",
doi = "10.1074/jbc.M412189200",
language = "English (US)",
volume = "280",
pages = "31076--31084",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "35",

}

TY - JOUR

T1 - Differential effects of lipoprotein lipase on tumor necrosis factor-α and interferon-γ-mediated gene expression in human endothelial cells

AU - Kota, Rama S.

AU - Ramana, Chilakamarti V.

AU - Tenorio, Fatima A.

AU - Enelow, Richard I.

AU - Rutledge, John C

PY - 2005/9/2

Y1 - 2005/9/2

N2 - Lipoprotein lipase (LPL) is a key enzyme in the hydrolysis of triglyceride-rich lipoproteine. In vascular diseases, such as atherosclerosis, inflammation plays an important role in the pathogenesis of the disease. We examined the role of LPL in modulating tumor necrosis factor-α (TNF-α)- and interferon-γ (IFN-γ)-mediated inflammatory cytokine signal transduction pathways in human aortic endothelial cells (HAECs). LPL significantly suppressed TNF-α-induced gene expression, and this suppression was reversed by tetrahydrolipstatin and heparinase. In contrast, LPL synergistically enhanced IFN-γ-induced gene expression in HAECs. To elucidate the molecular mechanisms of LPL action, we investigated the role of transcription factors nuclear factor kappa B (NF-κB) and signal transducer and activator of transcription factor 1 (Stat1). The anti-inflammatory response of LPL in suppressing TNF-α-induced gene expression was a result of its inhibition of NF-κB activity by the abrogation of IκB-α degradation and phosphorylation of the p65 subunit. Although LPL alone had no effect on Stat1 activation, LPL enhanced IFN-γ-induced phosphorylation of Stat1 on tyrosine 701 and serine 727, as well as Stat1-mediated transactivation. The synergistic effect of LPL on IFN-γ-induced Stat1 activation was mediated by enhanced activation of the tyrosine kinase JAK2 and was abrogated by LY294002, a specific inhibitor of the phosphatidylinositol 3′-kinase pathway. Our studies indicate that LPL has differential effects on several inflammatory pathways known to be important in atherosclerosis.

AB - Lipoprotein lipase (LPL) is a key enzyme in the hydrolysis of triglyceride-rich lipoproteine. In vascular diseases, such as atherosclerosis, inflammation plays an important role in the pathogenesis of the disease. We examined the role of LPL in modulating tumor necrosis factor-α (TNF-α)- and interferon-γ (IFN-γ)-mediated inflammatory cytokine signal transduction pathways in human aortic endothelial cells (HAECs). LPL significantly suppressed TNF-α-induced gene expression, and this suppression was reversed by tetrahydrolipstatin and heparinase. In contrast, LPL synergistically enhanced IFN-γ-induced gene expression in HAECs. To elucidate the molecular mechanisms of LPL action, we investigated the role of transcription factors nuclear factor kappa B (NF-κB) and signal transducer and activator of transcription factor 1 (Stat1). The anti-inflammatory response of LPL in suppressing TNF-α-induced gene expression was a result of its inhibition of NF-κB activity by the abrogation of IκB-α degradation and phosphorylation of the p65 subunit. Although LPL alone had no effect on Stat1 activation, LPL enhanced IFN-γ-induced phosphorylation of Stat1 on tyrosine 701 and serine 727, as well as Stat1-mediated transactivation. The synergistic effect of LPL on IFN-γ-induced Stat1 activation was mediated by enhanced activation of the tyrosine kinase JAK2 and was abrogated by LY294002, a specific inhibitor of the phosphatidylinositol 3′-kinase pathway. Our studies indicate that LPL has differential effects on several inflammatory pathways known to be important in atherosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=24744469233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24744469233&partnerID=8YFLogxK

U2 - 10.1074/jbc.M412189200

DO - 10.1074/jbc.M412189200

M3 - Article

C2 - 15994321

AN - SCOPUS:24744469233

VL - 280

SP - 31076

EP - 31084

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 35

ER -